254 related articles for article (PubMed ID: 38540124)
1. Endothelin-1 and Its Role in Cancer and Potential Therapeutic Opportunities.
Harrison M; Zinovkin D; Pranjol MZI
Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540124
[TBL] [Abstract][Full Text] [Related]
2. Role of the endothelin axis and its antagonists in the treatment of cancer.
Bagnato A; Loizidou M; Pflug BR; Curwen J; Growcott J
Br J Pharmacol; 2011 May; 163(2):220-33. PubMed ID: 21232046
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
Bagnato A; Rosanò L
Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
[TBL] [Abstract][Full Text] [Related]
5. The importance of endothelin axis in initiation, progression, and therapy of ovarian cancer.
Rosanò L; Spinella F; Bagnato A
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R395-404. PubMed ID: 20538897
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 promotes epithelial-mesenchymal transition in human chondrosarcoma cells by repressing miR-300.
Wu MH; Huang PH; Hsieh M; Tsai CH; Chen HT; Tang CH
Oncotarget; 2016 Oct; 7(43):70232-70246. PubMed ID: 27602960
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression.
Rosanò L; Spinella F; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
Exp Biol Med (Maywood); 2006 Jun; 231(6):1128-31. PubMed ID: 16741062
[TBL] [Abstract][Full Text] [Related]
8. The endothelin system as target for therapeutic interventions in cardiovascular and renal disease.
Eroglu E; Kocyigit I; Lindholm B
Clin Chim Acta; 2020 Jul; 506():92-106. PubMed ID: 32151622
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Targeting of Epithelial-to-Mesenchymal Transition in Colorectal Cancer.
Zafari N; Velayati M; Nassiri M; Khazaei M; Hassanian SM; Ferns GA; Avan A
Curr Pharm Des; 2022; 28(28):2298-2311. PubMed ID: 35909286
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-1 in Health and Disease.
Banecki KMRM; Dora KA
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511055
[TBL] [Abstract][Full Text] [Related]
11. The endothelin axis: a novel target for pharmacotherapy of female malignancies.
Smollich M; Wülfing P
Curr Vasc Pharmacol; 2007 Jul; 5(3):239-48. PubMed ID: 17627567
[TBL] [Abstract][Full Text] [Related]
12. [New expansion of endothelin research: perspectives for clinical application of endothelin-receptor antagonists].
Goto K; Miyauchi T
Nihon Yakurigaku Zasshi; 2003 Feb; 121(2):91-101. PubMed ID: 12616854
[TBL] [Abstract][Full Text] [Related]
13. ET-1 Promotes Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells via the microRNA-489-3p /TWIST Axis.
Tzeng HE; Tang CH; Tsai CH; Chiu CH; Wu MH; Yen Y
Onco Targets Ther; 2021; 14():5005-5018. PubMed ID: 34675545
[TBL] [Abstract][Full Text] [Related]
14. Functional interaction between endothelin-1 and ZEB1/YAP signaling regulates cellular plasticity and metastasis in high-grade serous ovarian cancer.
Sestito R; Tocci P; Roman C; Di Castro V; Bagnato A
J Exp Clin Cancer Res; 2022 Apr; 41(1):157. PubMed ID: 35477522
[TBL] [Abstract][Full Text] [Related]
15. β-arrestin1 at the cross-road of endothelin-1 signaling in cancer.
Rosanò L; Bagnato A
J Exp Clin Cancer Res; 2016 Jul; 35(1):121. PubMed ID: 27473335
[TBL] [Abstract][Full Text] [Related]
16. Permissive role of endothelin receptors in tumor metastasis.
Said N; Theodorescu D
Life Sci; 2012 Oct; 91(13-14):522-7. PubMed ID: 22846215
[TBL] [Abstract][Full Text] [Related]
17. Endothelin@25 - new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12.
Maguire JJ; Davenport AP
Br J Pharmacol; 2014 Dec; 171(24):5555-72. PubMed ID: 25131455
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 Drives Epithelial-Mesenchymal Transition in Hypertensive Nephroangiosclerosis.
Seccia TM; Caroccia B; Gioco F; Piazza M; Buccella V; Guidolin D; Guerzoni E; Montini B; Petrelli L; Pagnin E; Ravarotto V; Belloni AS; Calò LA; Rossi GP
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27444511
[TBL] [Abstract][Full Text] [Related]
19. The endothelin axis as therapeutic target in human malignancies: present and future.
Bagnato A
Curr Pharm Des; 2012; 18(19):2720-33. PubMed ID: 22390759
[TBL] [Abstract][Full Text] [Related]
20. The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?
Kirkby NS; Hadoke PW; Bagnall AJ; Webb DJ
Br J Pharmacol; 2008 Mar; 153(6):1105-19. PubMed ID: 17965745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
